Details

Autor(en) / Beteiligte

• Alamdari, Nasser Malekpour
• Afaghi, Siamak
• Rahimi, Fatemeh Sadat
• Tarki, Farzad Esmaeili
• Tavana, Sasan
• Zali, Alireza
• Fathi, Mohammad
• Besharat, Sara
• Bagheri, Leyla
• Pourmotahari, Fatemeh
• Irvani, Seyed Sina Naghibi
• Dabbagh, Ali
• Mousavi, Seyed Ali

Titel

Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran

Ist Teil von

• The Tohoku Journal of Experimental Medicine, 2020, Vol.252(1), pp.73-84

Ort / Verlag

Japan: Tohoku University Medical Press

Erscheinungsjahr

2020

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• The Coronavirus Disease 2019 (COVID-19) pandemic has killed many people worldwide since December 2019, and Iran has been among the most affected countries. In this retrospective study, we aimed to determine the prognostic factors associated with mortality in COVID-19 patients by analyzing 396 survived and 63 non-survived patients in Shahid Modarres Hospital, Tehran, Iran, from January 30th until April 5th, 2020. As the results, the BMI > 35 (p = 0.0003), lung cancer (p = 0.007), chronic kidney disease (p = 0.002), Immunocompromised condition (p = 0.003), and diabetes (p = 0.018) were more frequently observed in the expired group. The history of statins use was more common in the discharged group (p = 0.002), while there was no significant difference in the drug history of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, nonsteroidal anti-inflammatory drugs, aspirin, and/or steroids, and in the past-year influenza vaccination. Multivariable regression demonstrated rising odds of in-hospital death related with age (odds ratio (OR) = 1.055, p = 0.002), levels of C-reactive protein (CRP) (OR = 2.915, p < 0.001), creatinine (OR = 1.740, p = 0.023), lymphocyte count (OR = 0.999, p = 0.008), and magnesium level (OR = 0.032, p < 0.001) on admission. In conclusion, the patients with older age and higher BMI with lymphopenia, hypomagnesemia, elevated CRP and/or raised creatinine on admission are at higher risk of mortality due to the COVID-19 infection, which requires the physicians to use timely and strong therapeutic measures for such patients.